Stem Cell Based Therapies for Blindness: David Hinton - CIRM Science Writer's Seminar

David Hinton, Ph.D., spoke at the Scientific Writer’s Seminar, a workshop presented on September 17, 2008 at CIRM headquarters in San Francisco. Hinton has a CIRM grant to study the therapeutic potential of retinal pigment epithelial cell lines derived from human embryonic stem cells for retinal degeneration.

Hinton is a professor of pathology, neurosurgery, and ophthalmology at the Keck School of Medicine at the University of Southern California.

Disease Programs

Learn about how stem cell research could generate the therapies for many chronic diseases and injuries

See disease fact sheets

CIRM Stem Cell Blog